| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.35 | 5e-11 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.23 | 2e-08 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.29 | 3e-08 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-07 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-07 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-07 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-06 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-06 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-06 |